Publication & Citation Trends
Publications
16 total
1902P Comparison of cabozantinib (CABO) versus sunitinib (SUN) following first-line (1L) nivolumab plus ipilimumab (NIVO+IPI) for metastatic renal cell carcinoma (mRCC): A target trial emulation using real-world data from the International mRCC Database Consortium (IMDC) PDF
Cited by 2
OpenAlex
1893P Immune-related adverse events from contemporary first-line combination therapies in metastatic renal cell carcinoma: Results from the IMDC PDF
Cited by 1
OpenAlex
Healthcare cost by primary tumour, functioning status and treatment among patients with metastatic neuroendocrine tumours: The LyREMeNET study
Cited by 3
OpenAlex
ctDNA in Neuroendocrine Carcinoma of Gastroenteropancreatic Origin or of Unknown Primary: The CIRCAN-NEC Pilot Study
Cited by 30
OpenAlex
Demonstrated Cost-Effectiveness of a Telehomecare Program for Gestational Diabetes Mellitus Management
Cited by 47
OpenAlex
O6-methylguanine-DNA methyltransferase (MGMT) status in neuroendocrine tumors: a randomized phase II study (MGMT-NET) PDF
Cited by 36
OpenAlex
Research Topics
Neuroendocrine Tumor Research Advances
(9)
Lung Cancer Research Studies
(6)
Pancreatic and Hepatic Oncology Research
(4)
Neuroblastoma Research and Treatments
(4)
Renal cell carcinoma treatment
(3)
Affiliations
Hospices Civils de Lyon
Hôpital Edouard Herriot
Centre Hospitalier de l’Université de Montréal